Vivos Therapeutics, Inc. (VVOS)
$0.14+0.00%Close
SELLCRISIS · day 49
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $824,533
- Beta
- 6.07
- P/E (TTM)
- -0.07
- Short % float
- 89.72%
- Days to cover
- 1.0
- SI change
- +76.1%
- 1W
- -6.67%
- 1M
- -22.22%
- vs SPY 1W
- -6.53%
- vs SPY 1M
- -24.73%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VVOS?
- LOPJLB’s latest quantitative signal on Vivos Therapeutics, Inc. (VVOS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is VVOS in?
- Vivos Therapeutics, Inc. (VVOS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Vivos Therapeutics, Inc. (VVOS) do?
- Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snori…